Clarify Specific Data for Approval of Abbreviation New Drug Application | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-1997-P-0035

Clarify Specific Data for Approval of Abbreviation New Drug Application

Documents

Comments

Description

CLOSED DATE: 01/22/1998 Docket Status: CLOSED

Type	Title	Posted	Comments	Status
Other	Acknowledgement Letter from FDA DMB to Kleinfeld, Kaplan & Becker	Oct 22, 1997	--	--

CREAM

NDA 19-855

TRANS-ISOMERS

CIS

RACEMIC

ELIMITE

TOPICAL

GENERIC VERSION

5% PERMETHRIN